Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Share Price
Equities
6990
CNE1000062J1
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 473.80 HKD | +0.72% |
|
-0.55% | +20.81% |
| 01-07 | Sichuan Kelun-Biotech Biopharmaceutical says subscription for BOC structured deposit II terminated | RE |
| 01-07 | Sichuan Kelun-Biotech Subscribes to Wealth Management Products | MT |
| Capitalization | 98.71B 110B 14.17B 12.21B 11.37B 10.58B 19.71B 1,285B 21.2B 131B 51.56B 613B 53.12B 52.03B 2,239B | P/E ratio 2025 * |
-206x | P/E ratio 2026 * | 2,373x |
|---|---|---|---|---|---|
| Enterprise value | 95.78B 107B 13.75B 11.85B 11.03B 10.27B 19.12B 1,247B 20.57B 127B 50.03B 595B 51.55B 50.48B 2,172B | EV / Sales 2025 * |
49.1x | EV / Sales 2026 * | 30.7x |
| Free-Float |
59.59% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
More recommendations
More press releases
| 1 day | +0.72% | ||
| 1 week | -0.55% | ||
| Current month | +20.81% | ||
| 1 month | +16.53% | ||
| 3 months | +3.36% | ||
| 6 months | +23.26% | ||
| Current year | +20.81% |
| 1 week | 455.2 |  | 495 |
| 1 month | 389.4 | | 495 |
| Current year | 389.4 | | 495 |
| 1 year | 156 | | 581 |
| 3 years | 60.6 | | 581 |
| 5 years | 60.6 | | 581 |
| 10 years | 60.6 | | 581 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun You Ge
CEO | Chief Executive Officer | 54 | 28/02/2022 |
Ze Jian Zhou
DFI | Director of Finance/CFO | 43 | 16/08/2022 |
Xiang Yang Tan
CTO | Chief Tech/Sci/R&D Officer | 63 | 04/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ge Xin Liu
CHM | Chairman | 75 | 28/02/2022 |
Jin Ping Jin
BRD | Director/Board Member | 54 | 14/02/2023 |
Yue Dong Li
BRD | Director/Board Member | 49 | 14/02/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.72% | -0.55% | +191.39% | - | 14.17B | |
| -0.49% | 0.00% | +8.75% | +88.27% | 49.24B | |
| +0.71% | +5.27% | +96.79% | +9.03% | 44.64B | |
| +1.35% | -8.27% | +122.62% | +744.25% | 34.43B | |
| +2.76% | +9.16% | -2.62% | -23.88% | 27.35B | |
| -0.60% | +7.34% | +121.49% | -42.68% | 21.08B | |
| +0.97% | +0.14% | +44.75% | -20.98% | 20.89B | |
| -0.74% | -5.17% | +104.56% | +168.59% | 14.29B | |
| -1.33% | -13.41% | -10.46% | +271.24% | 13.14B | |
| Average | +0.37% | -0.56% | +75.25% | +149.23% | 26.58B | |
| Weighted average by Cap. | +0.50% | +0.50% | +68.83% | +152.64% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.95B 2.19B 280M 242M 225M 209M 390M 25.42B 419M 2.59B 1.02B 12.13B 1.05B 1.03B 44.27B | 3.11B 3.48B 447M 385M 359M 334M 621M 40.53B 669M 4.12B 1.63B 19.33B 1.68B 1.64B 70.6B |
| Net income | -541M -606M -77.7M -66.98M -62.36M -58.05M -108M -7.05B -116M -717M -283M -3.36B -291M -285M -12.28B | 16.72M 18.72M 2.4M 2.07M 1.93M 1.79M 3.34M 218M 3.59M 22.16M 8.74M 104M 9M 8.82M 379M |
| Net Debt | -2.93B -3.28B -420M -362M -337M -314M -585M -38.15B -629M -3.88B -1.53B -18.2B -1.58B -1.54B -66.44B | -3.3B -3.69B -473M -408M -380M -354M -658M -42.94B -708M -4.37B -1.72B -20.48B -1.77B -1.74B -74.78B |
More financial data
* Estimated data
Employees
1,870
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 473.80 $ | +0.72% | 337,000 |
| 15/01/26 | 470.40 $ | +0.86% | 355,487 |
| 14/01/26 | 466.40 $ | -3.00% | 784,300 |
| 13/01/26 | 480.80 $ | -1.68% | 657,118 |
| 12/01/26 | 489.00 $ | +2.64% | 563,747 |
Delayed Quote Hong Kong S.E., January 16, 2026 at 08:08 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
473.80HKD
Average target price
532.76HKD
Spread / Average Target
+12.44%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 6990 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition